Synbio salvages alcohol-free beer
Published in Nature Biotechnology
Synbio salvages alcohol-free beer
The characteristics of patents impacting availability of biosimilars
Published in Nature Biotechnology
The large number of biologic drug patents in the United States has contributed to delays in biosimilar availability.
Expanding global access to genetic therapies
Published in Nature Biotechnology
It is time to rethink intellectual property and pricing practices that prevent global access to genetic therapies.
Constructive principles for gene editing oversight
Published in Nature Biotechnology
Publisher Correction: Treg engineers take aim at autoimmunity
Published in Nature Biotechnology
Virtual meetings promise to eliminate geographical and administrative barriers and increase accessibility, diversity and...
...
Published in Nature Biotechnology
Conference organizers must adopt a novel, comprehensive approach to ensure increased accessibility, diversity and inclusivity of post-pandemic conferences.
Publisher Correction: Sickle cell gene therapies approach watershed
Published in Nature Biotechnology
Predicting disease variants using biodiversity and machine learning
Published in Nature Biotechnology
An algorithm that uses evolutionary data to predict disease variants makes a case for embracing computational evidence for clinical interpretation of genetic variation.
The DxConnect Virtual Biobank connects diagnostic researchers to clinical samples
Published in Nature Biotechnology
Publisher Correction: Top 20 translational researchers of 2020
Published in Nature Biotechnology
